Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 0 | 0 | 355 | 492 | 180 |
| Cost of Goods | N/A | N/A | 697 | 722 | 2,312 |
| Gross Profit | N/A | N/A | -342 | -230 | -2,132 |
| Operating Expenses | 12,389 | 18,981 | 26,834 | 37,899 | 28,134 |
| Operating Income | -12,389 | -18,981 | -26,479 | -37,407 | -29,954 |
| Interest Expense | 771 | 828 | 228 | 0 | 0 |
| Other Income | 2,883 | 3,569 | 11,415 | 2,954 | 4,304 |
| Pre-tax Income | -10,277 | -16,240 | -15,292 | -34,453 | -25,650 |
| Net Income Continuous | -10,277 | -16,240 | -15,292 | -34,453 | -25,650 |
| Net Income | $-10,277 | $-16,240 | $-15,292 | $-34,453 | $-25,650 |
| EPS Basic Total Ops | -1.45 | -6.66 | -5.20 | -12.30 | -9.45 |
| EPS Basic Continuous Ops | -1.34 | -5.25 | -5.22 | -12.25 | -9.45 |
| EPS Diluted Total Ops | -1.45 | -6.67 | -5.90 | -12.75 | -10.50 |
| EPS Diluted Continuous Ops | -1.34 | -5.25 | -5.22 | -12.20 | -10.50 |
| EPS Diluted Before Non-Recurring Items | -1.45 | -8.25 | -8.25 | -13.80 | -12.00 |
| EBITDA(a) | $-11,997 | $-18,511 | $-25,915 | $-36,640 | $-29,071 |